Christopher Turner

Christopher Turner

Chief Tech/Sci/R&D Officer chez NUVALENT, INC.

Fortune : 4 M $ au 31/03/2024

56 ans
Health Technology
Health Services
Consumer Services

Profil

Christopher D.
Turner
is currently the Chief Medical Officer at Nuvalent, Inc. Prior to his current position, he held various roles including Director-Pediatric Neuro Oncology Outcomes at Dana-Farber Cancer Institute, Inc., Director-Pediatric Neuro Oncology Outcomes Clinic at The Children's Hospital Corp., Head-Clinical Research at ARIAD Pharmaceuticals, Inc., Vice President-Clinical Science at Celldex Therapeutics, Inc., and Vice President-Clinical Development at Blueprint Medicines Corp.
Dr. Turner completed his undergraduate degree at Bowdoin College and obtained a doctorate from the University of Rochester School of Medicine & Dentistry.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
05/01/2024 47 813 ( 0,08% ) 4 M $ 31/03/2024

Postes actifs de Christopher Turner

SociétésPosteDébut
NUVALENT, INC. Chief Tech/Sci/R&D Officer 01/03/2021
Tous les postes actifs de Christopher Turner

Anciens postes connus de Christopher Turner

SociétésPosteFin
BLUEPRINT MEDICINES CORPORATION Corporate Officer/Principal 01/03/2021
CELLDEX THERAPEUTICS, INC. Corporate Officer/Principal 01/05/2018
ARIAD PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Christopher Turner

Formation de Christopher Turner

Bowdoin College Undergraduate Degree
University of Rochester School of Medicine & Dentistry Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Christopher Turner

Relations

39

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
CELLDEX THERAPEUTICS, INC.

Health Services

BLUEPRINT MEDICINES CORPORATION

Health Technology

NUVALENT, INC.

Health Technology

Entreprise privées3

Health Technology

Health Services

Health Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Christopher Turner